MedPath

Male Partner Involvement in the Prevention of MTCT of HIV

Phase 4
Completed
Conditions
HIV Infections
Registration Number
NCT00405990
Lead Sponsor
Imperial College London
Brief Summary

The study aims to invite male sexual partners to attend antenatal clinic with their pregnant partners to either acquire pregnancy information or undergo voluntary counselling and testing for HIV. To see if male sexual partner involvement will decrease sexual risk behaviour.

Detailed Description

We will enrol 1000 pregnant women; recruited from antenatal clinic at Khayelitsha Midwive and Obstetric Unit (MOU). Community sensitization activities will be implemented in the catchment community to encourage male partner participation.

At the booking visit all women will be offered antenatal care, HIV group education and VCT as usual. Thereafter women will be recruited to enrol into the study, after signing the consent form half of the cohort members will be randomly assigned to partner VCT (Group A) and half to partner pregnancy information (Group B). Men in group B will be offered VCT at the second interview late in pregnancy. However, VCT will be provided if requested by study participants at any stage of the study or if the female partner is HIV positive. Women in group A will be given a written invitation to hand to their partners to encourage them to invite their partners to come to the antenatal clinic for VCT. In group B, women will be given a written invitation to give to their partners to encourage their partners to attend a pregnancy information session at the antenatal clinic.

VCT will be offered again close to delivery for all women and men who were previously uninfected or of unknown status. For those found to be HIV-infected at a prior visit, CD4 and CD8 T-cell counts, viral load, and full blood count tests will be conducted. Both women and men will be referred to the Antiretroviral clinic where ARV will be offered if appropriate and formula feeding (or exclusive breastfeeding) will be recommended. Reasons for declining VCT and data on sexual behaviour and violence will be sought at each visit.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • To be eligible for participation, a woman must be less than 30 weeks pregnant at enrolment.
Exclusion Criteria
  • Women who are more than 30 weeks pregnant will be excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Percentage of partners agreeing to attend VCT.12 weeks
Secondary Outcome Measures
NameTimeMethod
Percentage of partners and pregnant women abstaining, faithful to one partner and using condoms consistently.12 weeks

Trial Locations

Locations (1)

Khayelitsha Midwive and Obstetric Unit Site B

🇿🇦

Cape Town, Western Cape, South Africa

© Copyright 2025. All Rights Reserved by MedPath